Clopidogrel Response Evaluated by VerifyNow P2Y12 Assay and Thrombelastography Analyzer in Patients

• 作 者: HuihuiLv[1]XiaoliYang[1]YahHan[1]YangtaiGuan[2]
• 机 构: Department of Neurology,Changhai Hospital,Second Military Medical University
• 出 处: 中国卒中学会第一届学术年会暨天坛国际脑血管会议2015
• 发表日期: 2015年期

　　Background: Poor response to clopidogrel is associated with recurrent ischemic events,and reliable platelet function tests are needed to identify low responders.Objective: This study aims to compare and assess the consistency of the two widely-used platelet function tests in China and overseas respectively, the VerifyNow P2Y12 Assay and the Thrombelastography (TEG) Analyzer, in acute ischemic stroke patients treated with Clopidogrel.